Back
Acumen Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
38
ABOS
Acumen Pharmaceuticals
Last Price:
2.26
Seasonality Move:
2.47%
Sell
19
NBY
NovaBay Pharmaceuticals
Last Price:
0.57
Seasonality Move:
-6.61%
Sell
38
Acumen Pharmaceuticals (ABOS)
is a Sell
Is Acumen Pharmaceuticals a Buy, Sell or Hold?
- The current Acumen Pharmaceuticals [ABOS] share price is $2.35. The Score for ABOS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ABOS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.60. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ABOS Stock Price Chart
What is Acumen Pharmaceuticals's stock price today?
-
The Acumen Pharmaceuticals share price today is $2.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
ABOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 43.07 | Sell |
| Chaikin Money Flow: | 127069 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.32 - 3.02) | Sell |
| Bollinger Bands (100): | (2.36 - 3.02) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 39.31 | Sell |
| Chaikin Money Flow: | 15384 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.63 - 0.75) | Sell |
| Bollinger Bands (100): | (0.29 - 1.25) | Sell |
ABOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.31 | Buy |
| 20-day SMA: | 2.61 | Sell |
| 50-day SMA: | 2.58 | Sell |
| 200-day SMA: | 3.03 | Sell |
| 8-day EMA: | 2.34 | Buy |
| 20-day EMA: | 2.49 | Sell |
| 50-day EMA: | 2.59 | Sell |
| 200-day EMA: | 2.99 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.64 | Sell |
| 20-day SMA: | 0.69 | Sell |
| 50-day SMA: | 0.67 | Sell |
| 200-day SMA: | 2.22 | Sell |
| 8-day EMA: | 0.63 | Sell |
| 20-day EMA: | 0.66 | Sell |
| 50-day EMA: | 0.71 | Sell |
| 200-day EMA: | 5.33 | Sell |
Acumen Pharmaceuticals Earnings Growth & ABOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and a decrease next year of $0.04 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Acumen Pharmaceuticals Technical Analysis
| Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||